2023 was a busy year for peer-reviewed journal contributions and we produced four Aparito white papers covering topics including vCOA development, the benefits of provisioned versus bring-your-own-device, and the merits of ePROs over paper-based PROs.

Journals

So You Want to Build Your Disease’s First Online Patient Registry: An Educational Guide for Patient Organizations Based on US and European Experience

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031688/

Development and usability testing of an ePRO solution for patients with inflammatory diseases in an ATMP basket trial

https://pubmed.ncbi.nlm.nih.gov/37812323/

Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): protocol of an observational study using momentary data assessments via mobile health app

https://bmjopen.bmj.com/content/13/8/e075736

A global neuronopathic Gaucher disease registry (GaRDIAN): a patient-led initiative

https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-02828-w

Considerations for patient and public involvement and engagement in health research

https://www.nature.com/articles/s41591-023-02445-x

Digitally enabled decentralised research: opportunities to improve the efficiency of clinical trials and observational studies

https://pubmed.ncbi.nlm.nih.gov/36810190/

Accelerometer-derived sleep measures in idiopathic dystonia: A UK Biobank cohort study

https://pubmed.ncbi.nlm.nih.gov/37547976/

White papers

Video-Based Assessments to Digitise COA: the story of SARAhome

Video-Based Assessments to Digitise COA: the story of SARAhome

Pixels or paper? Exploring Patient-Reported Outcomes (PROs) in Clinical Trials

Pixels or paper? Exploring Patient-Reported Outcomes (PROs) in Clinical Trials

Video-Based Assessments to Digitise COA: validating vTUG for Parkinson’s disease

Video-Based Assessments to Digitise COA: validating vTUG for Parkinson’s disease

Provisioned Devices vs BYOD in Clinical Trials

Provisioned Devices vs BYOD in Clinical Trials


Sign up for our newsletter to receive our latest papers, posters and platform updates direct to your inbox!